China Resources Pharmaceutical Group Limited (3320.HK)
HKD 4.95
(-0.4%)
HKD 4.95
(-0.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15 Billion | 10.89 Billion | 11.22 Billion | 6.27 Billion | 5.25 Billion | 8.24 Billion |
| Net Income | 4.25 Billion | 4.14 Billion | 3.76 Billion | 3.29 Billion | 3.28 Billion | 3.97 Billion |
| Depreciation & Amortization | 3.49 Billion | 3.15 Billion | 2.82 Billion | 2.44 Billion | 2.36 Billion | 1.51 Billion |
| Deferred income taxes | - | -7.71 Billion | -6.71 Billion | - | - | - |
| Stock-based compensation | 141.89 Million | 99.55 Million | 1.17 Million | - | - | - |
| Change in working capital | 1.76 Billion | -934.79 Million | 300.31 Million | -3.76 Billion | -2.01 Billion | -3.34 Billion |
| Other non-cash items | 10.36 Billion | 12.13 Billion | 11.04 Billion | 4.29 Billion | 1.61 Billion | 6.09 Billion |
| Investing Cash Flow | 640.59 Million | -3.29 Billion | -8.83 Billion | -2.02 Billion | 1.04 Billion | -9.8 Billion |
| Investments in PPE | -3.46 Billion | -3.35 Billion | -2.9 Billion | -2.21 Billion | -2.04 Billion | -1.51 Billion |
| Acquisitions | 4.96 Billion | -572.15 Million | -1.01 Billion | -82.95 Million | 1.03 Billion | -4.04 Billion |
| Investment purchases | -26.68 Billion | -3.04 Billion | -1.09 Billion | -371.44 Million | -1.6 Billion | -3.52 Billion |
| Sales/Maturities of investments | 25.76 Billion | 16.33 Million | 337 Thousand | 536.44 Million | 130.22 Million | 16.98 Billion |
| Other Investing Activities | 60.85 Million | 3.66 Billion | -3.82 Billion | 114.77 Million | 3.52 Billion | -17.69 Billion |
| Financing Cash Flow | -5.58 Billion | -9 Billion | 5.31 Billion | -3.6 Billion | -9.1 Billion | 4.66 Billion |
| Debt repayment | -219.89 Million | -5.05 Billion | -7.65 Billion | -207.26 Million | -19.59 Billion | -70.28 Billion |
| Dividends payments | -972.35 Million | -942.37 Million | -753.9 Million | -691.07 Million | -816.98 Million | -691.29 Million |
| Common Stock Repurchased | -571.1 Million | -483.44 Million | -86.76 Million | -145.43 Million | - | - |
| Common Stock Issuance | - | 3.35 Billion | -691.06 Million | -684.77 Million | - | - |
| Other Financing Activities | -3.12 Billion | -5.87 Billion | 14.5 Billion | -1.87 Billion | 11.3 Billion | 75.64 Billion |
| Accounts receivables | -6.99 Billion | -8.02 Billion | -5.19 Billion | -5.12 Billion | -7.58 Billion | -3.37 Billion |
| Accounts payables | 12.05 Billion | 9.36 Billion | 7.53 Billion | 1.54 Billion | 6.18 Billion | 223.66 Million |
| Inventory | -2.94 Billion | -2.63 Billion | -3.41 Billion | -805.54 Million | -537.47 Million | 29.48 Million |
| Other working capital | -338.95 Million | 360.28 Million | 1.37 Billion | 622.72 Million | -77.01 Million | -223.66 Million |
| Cash at beginning of period | 24.11 Billion | 25.32 Billion | 17.72 Billion | 17.13 Billion | 20.06 Billion | 14.17 Billion |
| Cash at end of period | 34.86 Billion | 24.11 Billion | 25.32 Billion | 17.72 Billion | 17.13 Billion | 16.63 Billion |
| Capital Expenditure | -3.46 Billion | -3.35 Billion | -2.9 Billion | -2.21 Billion | -2.04 Billion | -1.51 Billion |
| Effect of forex changes on cash | 9.66 Million | -429.25 Million | -362.68 Million | -853.8 Million | -228.07 Million | -651.8 Million |
| Net cash flow / Change in cash | 10.74 Billion | -1.2 Billion | 7.6 Billion | 584.8 Million | -2.92 Billion | 2.46 Billion |
| Free Cash Flow | 11.54 Billion | 7.54 Billion | 8.31 Billion | 4.05 Billion | 3.21 Billion | 6.73 Billion |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.82 Billion | 1.2 Billion | 4.25 Billion | 3.03 Billion | 4.14 Billion | 1.12 Billion |
| Depreciation & Amortization | 1.76 Billion | 1.76 Billion | 3.49 Billion | 1.71 Billion | 3.15 Billion | 1.54 Billion |
| Deferred income taxes | - | - | - | -16.29 Billion | -7.71 Billion | 6.09 Billion |
| Stock-based compensation | - | 75.24 Million | 141.89 Million | 80.96 Million | 99.55 Million | 101.78 Million |
| Change in working capital | -10.3 Billion | 13.72 Billion | 1.76 Billion | -13.28 Billion | -934.79 Million | 9.97 Billion |
| Other non-cash items | 46.71 Million | 4.61 Billion | 10.36 Billion | 19.24 Billion | 12.13 Billion | -3.58 Billion |
| Investing Cash Flow | 3.74 Billion | -2.57 Billion | 640.59 Million | 1.87 Billion | -3.29 Billion | -1.91 Billion |
| Investments in PPE | -1.14 Billion | -1.49 Billion | -3.46 Billion | -1.41 Billion | -3.35 Billion | -1.72 Billion |
| Acquisitions | 1.97 Billion | -1.03 Billion | 4.96 Billion | 1.4 Billion | -572.15 Million | -1.36 Billion |
| Investment purchases | -71.53 Million | - | -26.68 Billion | -8.98 Billion | -3.04 Billion | 12.91 Billion |
| Sales/Maturities of investments | 15.82 Billion | - | 25.76 Billion | 10.82 Billion | 16.33 Million | -15.34 Billion |
| Other Investing Activities | -18.63 Billion | -44.55 Million | 60.85 Million | 53.72 Million | 3.66 Billion | 3.61 Billion |
| Financing Cash Flow | 2.29 Billion | -16.06 Billion | -5.58 Billion | 12.74 Billion | -9 Billion | -16.68 Billion |
| Debt repayment | -5.85 Billion | - | -219.89 Million | -14.63 Billion | -5.05 Billion | -14.06 Billion |
| Dividends payments | - | -968.08 Million | -972.35 Million | - | -942.37 Million | -942.37 Million |
| Common Stock Repurchased | -82.21 Million | - | -571.1 Million | - | -483.44 Million | -150.7 Million |
| Common Stock Issuance | - | - | - | - | 3.35 Billion | 3.35 Billion |
| Other Financing Activities | -4.5 Billion | -15.1 Billion | -3.12 Billion | -1.52 Billion | -5.87 Billion | -4.55 Billion |
| Accounts receivables | -16.17 Billion | 12.48 Billion | -6.99 Billion | -19.35 Billion | -8.02 Billion | 7.42 Billion |
| Accounts payables | 10.93 Billion | - | 12.05 Billion | 11.02 Billion | 9.36 Billion | 3.72 Billion |
| Inventory | -5.58 Billion | 1.51 Billion | -2.94 Billion | -4.45 Billion | -2.63 Billion | -1.85 Billion |
| Other working capital | 520.41 Million | -271.21 Million | -338.95 Million | -499.56 Million | 360.28 Million | 671.63 Million |
| Cash at beginning of period | 32.39 Billion | 23.93 Billion | 24.11 Billion | 24.11 Billion | 25.32 Billion | 25.95 Billion |
| Cash at end of period | 30.08 Billion | 27.42 Billion | 34.86 Billion | 32.39 Billion | 24.11 Billion | 24.11 Billion |
| Capital Expenditure | -1.14 Billion | -1.49 Billion | -3.46 Billion | -1.41 Billion | -3.35 Billion | -1.72 Billion |
| Effect of forex changes on cash | - | 750.59 Million | 9.66 Million | -741 Million | -429.25 Million | 840.43 Million |
| Net cash flow / Change in cash | -2.31 Billion | 3.49 Billion | 10.74 Billion | 8.27 Billion | -1.2 Billion | -1.83 Billion |
| Free Cash Flow | -35.77 Million | 19.88 Billion | 11.54 Billion | -6.91 Billion | 7.54 Billion | 13.54 Billion |
CJPRF
PYHOF
FER
UHOIF
1679
027360